PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Rheumatology Unit, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.\', \'Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.\', \'Immunoallergology Unit, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.\', \'Rheumatology Unit, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy marta.mosca@unipi.it.\']
?:citedBy
  • -1
?:creator
?:doi
  • e00191410.1136/rmdopen-2021-001914
?:doi
?:hasPublicationType
?:journal
  • RMD open
is ?:pmid of
?:pmid
?:pmid
  • 34880126
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.169
?:rankingScore_hIndex
  • 13
is ?:relation_isRelatedTo_publication of
?:title
  • Efficacy of anti-SARS-CoV-2 mRNA vaccine in systemic autoimmune disorders: induction of high avidity and neutralising anti-RBD antibodies.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34880126>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34880126>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all